Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor TherapyCorinne Bousquet, Stéphane Pyronnet, Charline Lasfargues et al.|The Journal of Clinical Endocrinology & Metabolism|2011Cited by 87
Pancreatic tumours escape from translational control through 4E-BP1 lossYvan Martineau, Stéphane Pyronnet, R Azar et al.|Oncogene|2013Cited by 67
4E-BP restrains eIF4E phosphorylationDavid C. Muller, Yvan Martineau, Amandine Alard et al.|Translation|2013Cited by 29
Contribution of HIF-1α in <i>4E-BP1</i> Gene ExpressionRania Azar, Stéphane Pyronnet, Charline Lasfargues et al.|Molecular Cancer Research|2012Cited by 20
Changes in Translational Control after Pro-Apoptotic StressCharline Lasfargues, Stéphane Pyronnet, Yvan Martineau et al.|International Journal of Molecular Sciences|2012Cited by 15